Serveur d'exploration sur les récepteurs immunitaires végétaux

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach.

Identifieur interne : 000107 ( Main/Exploration ); précédent : 000106; suivant : 000108

Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach.

Auteurs : Muhammad Tahir Ul Qamar [République populaire de Chine] ; Zeeshan Shokat [Pakistan] ; Iqra Muneer [République populaire de Chine] ; Usman Ali Ashfaq [Pakistan] ; Hamna Javed [Pakistan] ; Farooq Anwar [Pakistan] ; Amna Bari [République populaire de Chine] ; Barira Zahid [République populaire de Chine] ; Nazamid Saari [Malaisie]

Source :

RBID : pubmed:32521680

Abstract

Respiratory syncytial virus (RSV) is primarily associated with respiratory disorders globally. Despite the availability of information, there is still no competitive vaccine available for RSV. Therefore, the present study has been designed to develop a multiepitope-based subunit vaccine (MEV) using a reverse vaccinology approach to curb RSV infections. Briefly, two highly antigenic and conserved proteins of RSV (glycoprotein and fusion protein) were selected and potential epitopes of different categories (B-cell and T-cell) were identified from them. Eminently antigenic and overlapping epitopes, which demonstrated strong associations with their respective human leukocyte antigen (HLA) alleles and depicted collective ~70% coverage of the world's populace, were shortlisted. Finally, 282 amino acids long MEV construct was established by connecting 13 major histocompatibility complex (MHC) class-I with two MHC class-II epitopes with appropriate adjuvant and linkers. Adjuvant and linkers were added to increase the immunogenic stimulation of the MEV. Developed MEV was stable, soluble, non-allergenic, non-toxic, flexible and highly antigenic. Furthermore, molecular docking and molecular dynamics (MD) simulations analyses were carried out. Results have shown a firm and robust binding affinity of MEV with human pathogenic toll-like receptor three (TLR3). The computationally mediated immune response of MEV demonstrated increased interferon-γ production, a significant abundance of immunoglobulin and activation of macrophages which are essential for immune-response against RSV. Moreover, MEV codons were optimized and in silico cloning was performed, to ensure its increased expression. These outcomes proposed that the MEV developed in this study will be a significant candidate against RSV to control and prevent RSV-related disorders if further investigated experimentally.

DOI: 10.3390/vaccines8020288
PubMed: 32521680
PubMed Central: PMC7350008


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach.</title>
<author>
<name sortKey="Tahir Ul Qamar, Muhammad" sort="Tahir Ul Qamar, Muhammad" uniqKey="Tahir Ul Qamar M" first="Muhammad" last="Tahir Ul Qamar">Muhammad Tahir Ul Qamar</name>
<affiliation wicri:level="1">
<nlm:affiliation>College of Life Science and Technology, Guangxi University, Nanning 530004, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>College of Life Science and Technology, Guangxi University, Nanning 530004</wicri:regionArea>
<wicri:noRegion>Nanning 530004</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shokat, Zeeshan" sort="Shokat, Zeeshan" uniqKey="Shokat Z" first="Zeeshan" last="Shokat">Zeeshan Shokat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000</wicri:regionArea>
<wicri:noRegion>Faisalabad 38000</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muneer, Iqra" sort="Muneer, Iqra" uniqKey="Muneer I" first="Iqra" last="Muneer">Iqra Muneer</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Life Sciences, University of Science and Technology of China, Hefei 230052, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences, University of Science and Technology of China, Hefei 230052</wicri:regionArea>
<placeName>
<settlement type="city">Hefei</settlement>
<region type="province">Anhui</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ashfaq, Usman Ali" sort="Ashfaq, Usman Ali" uniqKey="Ashfaq U" first="Usman Ali" last="Ashfaq">Usman Ali Ashfaq</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000</wicri:regionArea>
<wicri:noRegion>Faisalabad 38000</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Javed, Hamna" sort="Javed, Hamna" uniqKey="Javed H" first="Hamna" last="Javed">Hamna Javed</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000</wicri:regionArea>
<wicri:noRegion>Faisalabad 38000</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Anwar, Farooq" sort="Anwar, Farooq" uniqKey="Anwar F" first="Farooq" last="Anwar">Farooq Anwar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Chemistry, University of Sargodha, Sargodha 40100</wicri:regionArea>
<wicri:noRegion>Sargodha 40100</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bari, Amna" sort="Bari, Amna" uniqKey="Bari A" first="Amna" last="Bari">Amna Bari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070</wicri:regionArea>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zahid, Barira" sort="Zahid, Barira" uniqKey="Zahid B" first="Barira" last="Zahid">Barira Zahid</name>
<affiliation wicri:level="1">
<nlm:affiliation>Key Laboratory of Horticultural Plant Biology (Ministry of Education), Huazhong Agricultural University, Wuhan 430070, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Key Laboratory of Horticultural Plant Biology (Ministry of Education), Huazhong Agricultural University, Wuhan 430070</wicri:regionArea>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Saari, Nazamid" sort="Saari, Nazamid" uniqKey="Saari N" first="Nazamid" last="Saari">Nazamid Saari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Serdang 43400, Selangor</wicri:regionArea>
<wicri:noRegion>Selangor</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32521680</idno>
<idno type="pmid">32521680</idno>
<idno type="doi">10.3390/vaccines8020288</idno>
<idno type="pmc">PMC7350008</idno>
<idno type="wicri:Area/Main/Corpus">000112</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000112</idno>
<idno type="wicri:Area/Main/Curation">000112</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000112</idno>
<idno type="wicri:Area/Main/Exploration">000112</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach.</title>
<author>
<name sortKey="Tahir Ul Qamar, Muhammad" sort="Tahir Ul Qamar, Muhammad" uniqKey="Tahir Ul Qamar M" first="Muhammad" last="Tahir Ul Qamar">Muhammad Tahir Ul Qamar</name>
<affiliation wicri:level="1">
<nlm:affiliation>College of Life Science and Technology, Guangxi University, Nanning 530004, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>College of Life Science and Technology, Guangxi University, Nanning 530004</wicri:regionArea>
<wicri:noRegion>Nanning 530004</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shokat, Zeeshan" sort="Shokat, Zeeshan" uniqKey="Shokat Z" first="Zeeshan" last="Shokat">Zeeshan Shokat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000</wicri:regionArea>
<wicri:noRegion>Faisalabad 38000</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muneer, Iqra" sort="Muneer, Iqra" uniqKey="Muneer I" first="Iqra" last="Muneer">Iqra Muneer</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Life Sciences, University of Science and Technology of China, Hefei 230052, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences, University of Science and Technology of China, Hefei 230052</wicri:regionArea>
<placeName>
<settlement type="city">Hefei</settlement>
<region type="province">Anhui</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ashfaq, Usman Ali" sort="Ashfaq, Usman Ali" uniqKey="Ashfaq U" first="Usman Ali" last="Ashfaq">Usman Ali Ashfaq</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000</wicri:regionArea>
<wicri:noRegion>Faisalabad 38000</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Javed, Hamna" sort="Javed, Hamna" uniqKey="Javed H" first="Hamna" last="Javed">Hamna Javed</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000</wicri:regionArea>
<wicri:noRegion>Faisalabad 38000</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Anwar, Farooq" sort="Anwar, Farooq" uniqKey="Anwar F" first="Farooq" last="Anwar">Farooq Anwar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Chemistry, University of Sargodha, Sargodha 40100</wicri:regionArea>
<wicri:noRegion>Sargodha 40100</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bari, Amna" sort="Bari, Amna" uniqKey="Bari A" first="Amna" last="Bari">Amna Bari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070</wicri:regionArea>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zahid, Barira" sort="Zahid, Barira" uniqKey="Zahid B" first="Barira" last="Zahid">Barira Zahid</name>
<affiliation wicri:level="1">
<nlm:affiliation>Key Laboratory of Horticultural Plant Biology (Ministry of Education), Huazhong Agricultural University, Wuhan 430070, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Key Laboratory of Horticultural Plant Biology (Ministry of Education), Huazhong Agricultural University, Wuhan 430070</wicri:regionArea>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Saari, Nazamid" sort="Saari, Nazamid" uniqKey="Saari N" first="Nazamid" last="Saari">Nazamid Saari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Serdang 43400, Selangor</wicri:regionArea>
<wicri:noRegion>Selangor</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Vaccines</title>
<idno type="ISSN">2076-393X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Respiratory syncytial virus (RSV) is primarily associated with respiratory disorders globally. Despite the availability of information, there is still no competitive vaccine available for RSV. Therefore, the present study has been designed to develop a multiepitope-based subunit vaccine (MEV) using a reverse vaccinology approach to curb RSV infections. Briefly, two highly antigenic and conserved proteins of RSV (glycoprotein and fusion protein) were selected and potential epitopes of different categories (B-cell and T-cell) were identified from them. Eminently antigenic and overlapping epitopes, which demonstrated strong associations with their respective human leukocyte antigen (HLA) alleles and depicted collective ~70% coverage of the world's populace, were shortlisted. Finally, 282 amino acids long MEV construct was established by connecting 13 major histocompatibility complex (MHC) class-I with two MHC class-II epitopes with appropriate adjuvant and linkers. Adjuvant and linkers were added to increase the immunogenic stimulation of the MEV. Developed MEV was stable, soluble, non-allergenic, non-toxic, flexible and highly antigenic. Furthermore, molecular docking and molecular dynamics (MD) simulations analyses were carried out. Results have shown a firm and robust binding affinity of MEV with human pathogenic toll-like receptor three (TLR3). The computationally mediated immune response of MEV demonstrated increased interferon-γ production, a significant abundance of immunoglobulin and activation of macrophages which are essential for immune-response against RSV. Moreover, MEV codons were optimized and in silico cloning was performed, to ensure its increased expression. These outcomes proposed that the MEV developed in this study will be a significant candidate against RSV to control and prevent RSV-related disorders if further investigated experimentally.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">32521680</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">2076-393X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jun</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>Vaccines</Title>
<ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E288</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines8020288</ELocationID>
<Abstract>
<AbstractText>Respiratory syncytial virus (RSV) is primarily associated with respiratory disorders globally. Despite the availability of information, there is still no competitive vaccine available for RSV. Therefore, the present study has been designed to develop a multiepitope-based subunit vaccine (MEV) using a reverse vaccinology approach to curb RSV infections. Briefly, two highly antigenic and conserved proteins of RSV (glycoprotein and fusion protein) were selected and potential epitopes of different categories (B-cell and T-cell) were identified from them. Eminently antigenic and overlapping epitopes, which demonstrated strong associations with their respective human leukocyte antigen (HLA) alleles and depicted collective ~70% coverage of the world's populace, were shortlisted. Finally, 282 amino acids long MEV construct was established by connecting 13 major histocompatibility complex (MHC) class-I with two MHC class-II epitopes with appropriate adjuvant and linkers. Adjuvant and linkers were added to increase the immunogenic stimulation of the MEV. Developed MEV was stable, soluble, non-allergenic, non-toxic, flexible and highly antigenic. Furthermore, molecular docking and molecular dynamics (MD) simulations analyses were carried out. Results have shown a firm and robust binding affinity of MEV with human pathogenic toll-like receptor three (TLR3). The computationally mediated immune response of MEV demonstrated increased interferon-γ production, a significant abundance of immunoglobulin and activation of macrophages which are essential for immune-response against RSV. Moreover, MEV codons were optimized and in silico cloning was performed, to ensure its increased expression. These outcomes proposed that the MEV developed in this study will be a significant candidate against RSV to control and prevent RSV-related disorders if further investigated experimentally.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tahir Ul Qamar</LastName>
<ForeName>Muhammad</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0003-4832-4250</Identifier>
<AffiliationInfo>
<Affiliation>College of Life Science and Technology, Guangxi University, Nanning 530004, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shokat</LastName>
<ForeName>Zeeshan</ForeName>
<Initials>Z</Initials>
<Identifier Source="ORCID">0000-0003-4861-133X</Identifier>
<AffiliationInfo>
<Affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muneer</LastName>
<ForeName>Iqra</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>School of Life Sciences, University of Science and Technology of China, Hefei 230052, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ashfaq</LastName>
<ForeName>Usman Ali</ForeName>
<Initials>UA</Initials>
<AffiliationInfo>
<Affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Javed</LastName>
<ForeName>Hamna</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anwar</LastName>
<ForeName>Farooq</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bari</LastName>
<ForeName>Amna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zahid</LastName>
<ForeName>Barira</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Key Laboratory of Horticultural Plant Biology (Ministry of Education), Huazhong Agricultural University, Wuhan 430070, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saari</LastName>
<ForeName>Nazamid</ForeName>
<Initials>N</Initials>
<Identifier Source="ORCID">0000-0002-4185-9415</Identifier>
<AffiliationInfo>
<Affiliation>Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>Postdoctoral Research Grant</GrantID>
<Agency>Guangxi University</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>Research grant</GrantID>
<Agency>Universiti Putra Malaysia</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>06</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Vaccines (Basel)</MedlineTA>
<NlmUniqueID>101629355</NlmUniqueID>
<ISSNLinking>2076-393X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Subunit vaccine</Keyword>
<Keyword MajorTopicYN="N">computational approaches</Keyword>
<Keyword MajorTopicYN="N">multiepitope-based vaccine</Keyword>
<Keyword MajorTopicYN="N">respiratory disorders</Keyword>
<Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>05</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>05</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32521680</ArticleId>
<ArticleId IdType="pii">vaccines8020288</ArticleId>
<ArticleId IdType="doi">10.3390/vaccines8020288</ArticleId>
<ArticleId IdType="pmc">PMC7350008</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Vaccines (Basel). 2019 Aug 12;7(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31409021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2019 Feb 5;9(1):1433</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30723263</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Bioinformatics. 2013;14 Suppl 6:S4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23735058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2009 Jan;37(Database issue):D355-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18996896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Aug;85(15):7788-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21613394</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W384-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23737448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2001 Apr;14(2):430-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11292646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Struct Biol. 2003 Dec;10(12):980</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14634627</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Rep. 2018 Nov 20;25(8):2121-2131.e5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30463010</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comput Math Methods Med. 2012;2012:842329</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22997539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Electrophoresis. 1993 Oct;14(10):1023-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8125050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2018 Feb;23(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29409569</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Vaccines. 2016;15(1):53-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26506139</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anticancer Drugs. 2019 Apr;30(4):363-373</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30499778</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1987 Jun 12;236(4807):1448-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3296194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2017 Aug 15;7(1):8285</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28811600</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Res Int. 2014;2014:689219</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25045691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Genet Evol. 2020 Jun;80:104199</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31962160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharm Anal. 2020 Mar 26;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32296570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W513-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18515843</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Proteome Res. 2020 Jun 5;19(6):2304-2315</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32308001</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proteins. 2006 Oct 1;65(1):40-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16894596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioinformatics. 2000 Apr;16(4):404-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10869041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 1987 Feb 11;15(3):1281-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3547335</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D32-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21071399</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2001 Oct 15;20 Suppl 1:S32-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11587807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1985 Oct;66 ( Pt 10):2111-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2413163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Struct Biol. 2002 Apr;12(2):190-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11959496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2005 Apr;11(4 Suppl):S45-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15812489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2013 Mar 19;5(3):873-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23518574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proteins. 2003 Feb 15;50(3):437-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12557186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1993 Oct;168(4):1024-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8376814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Molecules. 2018 Aug 25;23(9):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30149624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2017 Feb 13;8:14158</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28194013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathog Glob Health. 2018 May;112(3):123-131</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29528265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2016 Jul 8;44(W1):W449-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27131374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2018 Mar 6;14(3):e1006935</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29509814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Bioinformatics. 2007 Jan 05;8:4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17207271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9902-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26216991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pharm Sci. 2020 Apr 30;147:105279</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32119992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Med. 2019 Nov 8;17(1):362</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31703698</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C154-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21956165</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 1997 Jul;15(10):1130-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9269057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Rev Immunol. 2008;28(2):159-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18540829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W306-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25883144</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2013;372:3-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24362682</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Discov Today. 2009 Jul;14(13-14):684-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19379830</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioinformatics. 2019 Feb 15;35(4):694-695</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30101282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2003 Sep;47(9):2804-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12936977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2017 Aug 23;7(1):9232</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28835708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comput Biol Chem. 2016 Jun;62:82-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27107181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PeerJ. 2017 Oct 27;5:e3970</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29085762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2018 Feb;15(2):182-184</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28890542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomol Struct Dyn. 2017 Mar;35(4):791-804</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26984239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biochem. 2016 Apr;117(4):836-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26506511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2019 Jun 6;37(26):3457-3463</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31097352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microb Pathog. 2019 Jul;132:243-253</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31075428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Immunol. 2008 Jun;20(3):332-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18417336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2016 Feb 1;213(3):411-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26259809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2018 Jul 27;9:1695</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30100904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jun;78(11):6043-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15141002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W407-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17517781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Sep 13;8(9):e73957</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24058508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2016 Aug;161(8):2351-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27216929</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1993 Jan;167(1):191-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8418166</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W406-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23748950</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comput Appl Biosci. 1995 Dec;11(6):681-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8808585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Bioinformatics. 2006 Mar 17;7:153</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16545123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Bioinformatics. 2010 Aug 18;11:431</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20718988</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 May 1;375(9725):1545-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20399493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomol Struct Dyn. 2019 Nov 20;:1-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31709929</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W526-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15980527</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biochem. 2018 Sep;119(9):7631-7642</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29900580</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol Res. 2018 Oct 8;2018:6718083</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30402510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioinformatics. 2014 Mar 15;30(6):846-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24167156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Vaccine Res. 2017 Jan;6(1):15-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28168169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Med. 2018 Oct 27;16(1):298</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30368237</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Chem Inf Model. 2014 Jul 28;54(7):1951-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24850022</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Chem Inf Model. 2011 Jan 24;51(1):69-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21117705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2017 May 25;35(23):3096-3103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28456528</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2018 Apr 27;14(4):e1006112</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29702641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 1994 Sep;13(9):792-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7808848</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Rev. 2011 Jan;239(1):149-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21198670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2018 Jul 2;46(W1):W338-W343</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29762700</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proteins. 2011;79 Suppl 10:161-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21987485</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Immunol. 2020 Apr;120:146-163</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32126449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2018 Oct 31;8(1):16107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30382118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acc Chem Res. 2000 Dec;33(12):889-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11123888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 2004 Sep;103(3):245-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15464592</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Protoc. 2012 Jul 19;7(8):1511-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22814390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2017 Jan;30(1):277-319</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27903593</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proteins. 2011 Jun;79(6):1940-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21491494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2018 Sep;15(9):815-826</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28287115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2019 Sep 12;10:2152</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31572372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 1996 Sep;14(13):1214-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8961507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Comput Biol. 2013 Oct;9(10):e1003266</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24204222</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2002 Jun 1;168(11):5499-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12023344</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2018 Apr 19;36(17):2262-2272</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29571972</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Eng. 2001 Aug;14(8):529-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11579220</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biol Macromol. 2019 Feb 1;122:1203-1211</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30219509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antibodies (Basel). 2018 Jun 30;7(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31544875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Apr 16;5(4):e9862</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20419125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Genet Evol. 2019 Oct;74:103936</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31233780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Bioinformatics. 2008 Dec 02;9:514</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19055730</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Malaisie</li>
<li>Pakistan</li>
<li>République populaire de Chine</li>
</country>
<region>
<li>Anhui</li>
<li>Hubei</li>
</region>
<settlement>
<li>Hefei</li>
<li>Wuhan</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Tahir Ul Qamar, Muhammad" sort="Tahir Ul Qamar, Muhammad" uniqKey="Tahir Ul Qamar M" first="Muhammad" last="Tahir Ul Qamar">Muhammad Tahir Ul Qamar</name>
</noRegion>
<name sortKey="Bari, Amna" sort="Bari, Amna" uniqKey="Bari A" first="Amna" last="Bari">Amna Bari</name>
<name sortKey="Muneer, Iqra" sort="Muneer, Iqra" uniqKey="Muneer I" first="Iqra" last="Muneer">Iqra Muneer</name>
<name sortKey="Zahid, Barira" sort="Zahid, Barira" uniqKey="Zahid B" first="Barira" last="Zahid">Barira Zahid</name>
</country>
<country name="Pakistan">
<noRegion>
<name sortKey="Shokat, Zeeshan" sort="Shokat, Zeeshan" uniqKey="Shokat Z" first="Zeeshan" last="Shokat">Zeeshan Shokat</name>
</noRegion>
<name sortKey="Anwar, Farooq" sort="Anwar, Farooq" uniqKey="Anwar F" first="Farooq" last="Anwar">Farooq Anwar</name>
<name sortKey="Ashfaq, Usman Ali" sort="Ashfaq, Usman Ali" uniqKey="Ashfaq U" first="Usman Ali" last="Ashfaq">Usman Ali Ashfaq</name>
<name sortKey="Javed, Hamna" sort="Javed, Hamna" uniqKey="Javed H" first="Hamna" last="Javed">Hamna Javed</name>
</country>
<country name="Malaisie">
<noRegion>
<name sortKey="Saari, Nazamid" sort="Saari, Nazamid" uniqKey="Saari N" first="Nazamid" last="Saari">Nazamid Saari</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PlantImRecepV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000107 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000107 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PlantImRecepV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32521680
   |texte=   Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32521680" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PlantImRecepV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat Nov 21 12:33:18 2020. Site generation: Sat Nov 21 12:33:47 2020